2709. Breakthrough fungal infection after isavuconazole primary prophylaxis in patients with hematologic malignancy and hematopoietic stem cell transplant: Systematic Review

BACKGROUND: Isavuconazole (ISA) is a relatively newer triazole with a broad spectrum of anti-fungal activity and has been used for both treatment and prophylaxis of invasive fungal infections (IFIs) in patients with hematologic malignancy (HM) and hematopoietic stem cell transplant (HSCT) with a mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Keiko, Haraguchi, Mizuki, Kimura, Muneyoshi, Araoka, Hideki, Reynolds, John M, Raja, Mohammed, Natori, Yoichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678264/
http://dx.doi.org/10.1093/ofid/ofad500.2320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678264/
http://dx.doi.org/10.1093/ofid/ofad500.2320

Ejemplares similares